Nuveen Asset Management’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$63.8M Buy
524,579
+50,379
+11% +$6.13M 0.02% 546
2024
Q3
$59.2M Sell
474,200
-9,035
-2% -$1.13M 0.02% 574
2024
Q2
$76.4M Sell
483,235
-59,340
-11% -$9.38M 0.02% 483
2024
Q1
$70.2M Buy
542,575
+9,318
+2% +$1.21M 0.02% 525
2023
Q4
$51.4M Sell
533,257
-28,325
-5% -$2.73M 0.02% 593
2023
Q3
$68.1M Sell
561,582
-26,429
-4% -$3.2M 0.02% 474
2023
Q2
$67.3M Buy
588,011
+56,982
+11% +$6.53M 0.02% 482
2023
Q1
$73.2M Buy
531,029
+181,380
+52% +$25M 0.03% 440
2022
Q4
$45.3M Buy
349,649
+22,780
+7% +$2.95M 0.02% 575
2022
Q3
$36.1M Buy
326,869
+7,326
+2% +$810K 0.01% 671
2022
Q2
$24M Buy
319,543
+7,251
+2% +$544K 0.01% 927
2022
Q1
$25.3M Sell
312,292
-44,142
-12% -$3.57M 0.01% 1037
2021
Q4
$32.1M Sell
356,434
-60,400
-14% -$5.44M 0.01% 945
2021
Q3
$38.5M Sell
416,834
-36,500
-8% -$3.38M 0.01% 835
2021
Q2
$35.2M Buy
453,334
+72,341
+19% +$5.62M 0.01% 951
2021
Q1
$28.4M Sell
380,993
-116,634
-23% -$8.69M 0.01% 1062
2020
Q4
$84.8M Buy
497,627
+59,775
+14% +$10.2M 0.03% 480
2020
Q3
$61.5M Buy
437,852
+20,430
+5% +$2.87M 0.02% 510
2020
Q2
$66.9M Buy
417,422
+81,180
+24% +$13M 0.03% 479
2020
Q1
$32.9M Buy
336,242
+45,838
+16% +$4.48M 0.02% 642
2019
Q4
$37.5M Buy
290,404
+3,688
+1% +$476K 0.01% 825
2019
Q3
$21.6M Sell
286,716
-23,458
-8% -$1.77M 0.01% 1084
2019
Q2
$47.1M Buy
310,174
+283,766
+1,075% +$43.1M 0.02% 704
2019
Q1
$3.15M Buy
+26,408
New +$3.15M 0.02% 578
2018
Q2
Sell
-3,866
Closed -$286K 1087
2018
Q1
$286K Sell
3,866
-16,597
-81% -$1.23M ﹤0.01% 984
2017
Q4
$1.14M Sell
20,463
-10,014
-33% -$557K 0.01% 713
2017
Q3
$1.38M Sell
30,477
-1,338
-4% -$60.7K 0.01% 687
2017
Q2
$1.07M Buy
31,815
+3,226
+11% +$109K 0.01% 740
2017
Q1
$846K Buy
28,589
+10,048
+54% +$297K 0.01% 1021
2016
Q4
$509K Buy
18,541
+614
+3% +$16.9K ﹤0.01% 1286
2016
Q3
$1.1M Buy
+17,927
New +$1.1M 0.01% 1034